JYNNEOS/IMVANEX/IMVAMUNE (MVA-BN)
Prevention of Smallpox and Mpox (Monkeypox)
Approved/CommercialMarketed
Key Facts
Indication
Prevention of Smallpox and Mpox (Monkeypox)
Phase
Approved/Commercial
Status
Marketed
Company
About Bavarian Nordic
Bavarian Nordic is a publicly traded vaccine specialist with a firm focus on developing and manufacturing life-saving immunizations. The company has demonstrated strong commercial momentum, particularly in its Travel Health business, and has been a key supplier of a non-replicating smallpox/mpox vaccine for global public health stockpiles. Its strategy leverages a fully integrated model from R&D through manufacturing to address infectious disease threats.
View full company profile